Cargando…

Endovascular surgery for the treatment of purulent and necrotic complications in diabetic foot syndrome

Background: Diabetic foot syndrome (DFS) causes damage to the peripheral arteries in 50% of patients with diabetes mellitus (DM). The purpose of this study was to evaluate the efficacy of endovascular interventions, stenting, and balloon angioplasty for the treatment of patients with purulent and ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakanov, Murat K., Zhakiev, Bazylbek S., Karsakbayev, Uteugaly G., Kurmanbayev, Bulat A., Taishibayev, Kairat R., Sagynganov, Serik K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iran University of Medical Sciences 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683799/
https://www.ncbi.nlm.nih.gov/pubmed/34956952
http://dx.doi.org/10.47176/mjiri.35.106
_version_ 1784617494860791808
author Jakanov, Murat K.
Zhakiev, Bazylbek S.
Karsakbayev, Uteugaly G.
Kurmanbayev, Bulat A.
Taishibayev, Kairat R.
Sagynganov, Serik K.
author_facet Jakanov, Murat K.
Zhakiev, Bazylbek S.
Karsakbayev, Uteugaly G.
Kurmanbayev, Bulat A.
Taishibayev, Kairat R.
Sagynganov, Serik K.
author_sort Jakanov, Murat K.
collection PubMed
description Background: Diabetic foot syndrome (DFS) causes damage to the peripheral arteries in 50% of patients with diabetes mellitus (DM). The purpose of this study was to evaluate the efficacy of endovascular interventions, stenting, and balloon angioplasty for the treatment of patients with purulent and necrotic lesions in DFS. Methods: This was a retrospective study. During 2019-2020, stenting and balloon angioplasty were performed in 51 patients (study group) with purulent and necrotic complications of diabetic foot with limb ischemia. There were 32 women (62.7%) and 19 men (37.3%). The age of the patients varied from 45 to 81 years. Endovascular interventions were performed in combination with conservative therapy and topical treatment on 2 to 3 days after the debridement of the purulent lesions. To assess the outcomes of endovascular interventions, we studied the nature of changes in arterial circulation in the lower extremities. The mean blood flow velocity was calculated using the Doppler ultrasonography. The study was performed on the popliteal artery (PA), the posterior tibial artery (PTA), and on the dorsalis pedis artery. In this study, patients were divided into 2 groups: the study group— those who received endovascular intervention— and the control group— those who received only conservative therapy, which included local treatment without surgery. Results: The weightbearing function of the foot at discharge from the hospital was preserved in 94.2% (48 patients) of the study group and in 73.4% (22 patients) of the control group. During the next 6 months, repeated small foot surgeries were required in 7.3% (3 patients) of patients from the study group and in 20% (4 patients) of patients from the control group. Six months after discharge, the weightbearing function of the foot was preserved in all the patients from the study group available for follow-up and in 85% of the patients from the control group. Conclusion: The results of the study demonstrate the positive corrective effects of endovascular interventions, stenting, and balloon angioplasty on the clinical course of ischemic and neuroischemic forms of DFS.
format Online
Article
Text
id pubmed-8683799
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Iran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-86837992021-12-23 Endovascular surgery for the treatment of purulent and necrotic complications in diabetic foot syndrome Jakanov, Murat K. Zhakiev, Bazylbek S. Karsakbayev, Uteugaly G. Kurmanbayev, Bulat A. Taishibayev, Kairat R. Sagynganov, Serik K. Med J Islam Repub Iran Original Article Background: Diabetic foot syndrome (DFS) causes damage to the peripheral arteries in 50% of patients with diabetes mellitus (DM). The purpose of this study was to evaluate the efficacy of endovascular interventions, stenting, and balloon angioplasty for the treatment of patients with purulent and necrotic lesions in DFS. Methods: This was a retrospective study. During 2019-2020, stenting and balloon angioplasty were performed in 51 patients (study group) with purulent and necrotic complications of diabetic foot with limb ischemia. There were 32 women (62.7%) and 19 men (37.3%). The age of the patients varied from 45 to 81 years. Endovascular interventions were performed in combination with conservative therapy and topical treatment on 2 to 3 days after the debridement of the purulent lesions. To assess the outcomes of endovascular interventions, we studied the nature of changes in arterial circulation in the lower extremities. The mean blood flow velocity was calculated using the Doppler ultrasonography. The study was performed on the popliteal artery (PA), the posterior tibial artery (PTA), and on the dorsalis pedis artery. In this study, patients were divided into 2 groups: the study group— those who received endovascular intervention— and the control group— those who received only conservative therapy, which included local treatment without surgery. Results: The weightbearing function of the foot at discharge from the hospital was preserved in 94.2% (48 patients) of the study group and in 73.4% (22 patients) of the control group. During the next 6 months, repeated small foot surgeries were required in 7.3% (3 patients) of patients from the study group and in 20% (4 patients) of patients from the control group. Six months after discharge, the weightbearing function of the foot was preserved in all the patients from the study group available for follow-up and in 85% of the patients from the control group. Conclusion: The results of the study demonstrate the positive corrective effects of endovascular interventions, stenting, and balloon angioplasty on the clinical course of ischemic and neuroischemic forms of DFS. Iran University of Medical Sciences 2021-08-18 /pmc/articles/PMC8683799/ /pubmed/34956952 http://dx.doi.org/10.47176/mjiri.35.106 Text en © 2021 Iran University of Medical Sciences https://creativecommons.org/licenses/by-nc-sa/1.0/This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial-ShareAlike 1.0 License (CC BY-NC-SA 1.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Article
Jakanov, Murat K.
Zhakiev, Bazylbek S.
Karsakbayev, Uteugaly G.
Kurmanbayev, Bulat A.
Taishibayev, Kairat R.
Sagynganov, Serik K.
Endovascular surgery for the treatment of purulent and necrotic complications in diabetic foot syndrome
title Endovascular surgery for the treatment of purulent and necrotic complications in diabetic foot syndrome
title_full Endovascular surgery for the treatment of purulent and necrotic complications in diabetic foot syndrome
title_fullStr Endovascular surgery for the treatment of purulent and necrotic complications in diabetic foot syndrome
title_full_unstemmed Endovascular surgery for the treatment of purulent and necrotic complications in diabetic foot syndrome
title_short Endovascular surgery for the treatment of purulent and necrotic complications in diabetic foot syndrome
title_sort endovascular surgery for the treatment of purulent and necrotic complications in diabetic foot syndrome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683799/
https://www.ncbi.nlm.nih.gov/pubmed/34956952
http://dx.doi.org/10.47176/mjiri.35.106
work_keys_str_mv AT jakanovmuratk endovascularsurgeryforthetreatmentofpurulentandnecroticcomplicationsindiabeticfootsyndrome
AT zhakievbazylbeks endovascularsurgeryforthetreatmentofpurulentandnecroticcomplicationsindiabeticfootsyndrome
AT karsakbayevuteugalyg endovascularsurgeryforthetreatmentofpurulentandnecroticcomplicationsindiabeticfootsyndrome
AT kurmanbayevbulata endovascularsurgeryforthetreatmentofpurulentandnecroticcomplicationsindiabeticfootsyndrome
AT taishibayevkairatr endovascularsurgeryforthetreatmentofpurulentandnecroticcomplicationsindiabeticfootsyndrome
AT sagynganovserikk endovascularsurgeryforthetreatmentofpurulentandnecroticcomplicationsindiabeticfootsyndrome